×
Evolus Long Term Debt 2016-2024 | EOLS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Evolus long term debt from 2016 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Evolus Long Term Debt 2016-2024 | EOLS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Evolus long term debt from 2016 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$194.8B
Boston Scientific (BSX)
$139.8B
Stryker (SYK)
$139.4B
EssilorLuxottica (ESLOY)
$110.1B
Medtronic (MDT)
$103.4B
Lonza Group Ag (LZAGY)
$43.7B
Haleon (HLN)
$41.2B
GE HealthCare Technologies (GEHC)
$38.7B
ResMed (RMD)
$34.3B
Terumo (TRUMY)
$28B
Koninklijke Philips (PHG)
$24.3B
Zimmer Biomet Holdings (ZBH)
$20.8B
Insulet (PODD)
$19.1B
Baxter (BAX)
$15B
Smith & Nephew SNATS (SNN)
$10.5B
Bio-Rad Laboratories (BIO)
$9.6B
BellRing Brands (BRBR)
$9.1B
Demant (WILYY)
$8.6B
Lantheus Holdings (LNTH)
$6.7B
Haemonetics (HAE)
$3.9B
ICU Medical (ICUI)
$3.8B
Prestige Consumer Healthcare (PBH)
$3.7B
Perrigo (PRGO)
$3.3B
Envista Holdings (NVST)
$3.2B
QuidelOrtho (QDEL)
$3.1B
Shandong Weigao Medical Polymer (SHWGF)
$3B
Neogen (NEOG)
$2.7B
GN Store Nord (GNNDY)
$2.6B
LeMaitre Vascular (LMAT)
$2.1B
Green Thumb Industries (GTBIF)
$1.6B